MFAP1B activators refer to a class of compounds that can enhance the activity of the protein encoded by the MFAP1B gene. This protein is associated with the structure and function of microfibrils, which are important components of the extracellular matrix. Identifying activators for MFAP1B involves initial assay development, where a robust and quantifiable measure of MFAP1B activity is established. Typically, this may involve the use of an in vitro assay system that can monitor the incorporation of the MFAP1B protein into microfibril structures or its interaction with other microfibril-associated proteins. Once such an assay is developed, it can be used in a high-throughput screening (HTS) setup to test a large library of chemical compounds. The objective is to identify molecules that lead to an increase in the activity or interaction of MFAP1B with microfibrils, as measured by the assay. Compounds that yield a positive signal in this primary screen are selected for further analysis to confirm their activity and specificity towards MFAP1B.
The secondary stage of development for MFAP1B activators entails more rigorous validation of the compounds that passed the initial screening. Techniques such as surface plasmon resonance (SPR) and isothermal titration calorimetry (ITC) can be utilized to assess the direct interaction between these compounds and the MFAP1B protein. These biophysical methods can provide detailed information about the binding affinity, thermodynamics, and kinetics of the interaction. In conjunction with these techniques, structural studies, including X-ray crystallography or cryo-electron microscopy (cryo-EM), may be employed to elucidate the precise molecular interactions between MFAP1B and the activators. Such structural insights are invaluable for understanding the mechanism by which these compounds enhance the protein's activity. Moreover, this structural knowledge can inform the chemical modification of these activators to improve their efficacy and specificity.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
A polyphenol that inhibits several protein kinases. This inhibition can diminish competitive signaling, potentially enhancing MFAP1B's role in elastic fiber assembly. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
Activates protein kinase C (PKC), which may phosphorylate proteins involved in extracellular matrix organization, indirectly enhancing MFAP1B's function. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
A PI3K inhibitor which could upregulate compensatory pathways, potentially leading to the enhanced interaction of MFAP1B with fibrillin-1. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $165.00 $322.00 $570.00 $907.00 $1727.00 | 7 | |
S1P binds to its receptors, potentially causing cytoskeletal rearrangements that could enhance MFAP1B-mediated microfibril interactions. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A calcium ionophore that increases intracellular calcium, possibly enhancing MFAP1B's role in calcium-dependent signaling related to tissue elasticity. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
A broad-spectrum protein kinase inhibitor that could, by reducing kinase activity, indirectly enhance the stability of microfibrils where MFAP1B is involved. | ||||||